VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1752272
Sex: F
Age:
State: MD

Vax Date: 02/20/2021
Onset Date: 03/04/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Rash spread to back & shoulders; Rash spread to chest; rash appeared on forearms; This is a spontaneous report from a contactable consumer (patient) reported for self. A 67-years-old female non- pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EL9264), dose 2 via an unspecified route of administration, administered in Arm Left on 20Feb2021 at 14:30 (at the age of 67-years-old) as a DOSE 2, SINGLE for covid-19 immunisation at Public Health Clinic. The patient medical history included hypertension (High blood pressure), hypothyroidism (hypothyroid) and obesity (obese) all from an unknown date and unknown if ongoing. Concomitant medications received in two weeks included lisinopril (LISINOPRIL), levothyroxine, liothyronine (NP THYROID), berberine (BERBERINE) and glycerine monolaurate, inosine (MONOLAURIN [GLYCERINE MONOLAURATE;INOSINE]) all were taken for an unspecified indication, start and stop date were not reported. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN5318), dose 1 via an unspecified route of administration, administered in Arm Left on 30Jan2021 at 02:00 PM (at the age of 67-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. Patient had no Known allergies. The patient did not have COVID prior vaccination and was not tested for covid post vaccination. The patient experienced rash appeared on forearms on 04Mar2021, rash spread to chest on 10Mar2021 and rash spread to back & shoulders on 11Mar2021, does not itch. No treatment was received for the event. Outcome of all the events were not resolved. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752273
Sex: F
Age:
State: IL

Vax Date: 03/09/2021
Onset Date: 03/09/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: 101.8 fever; significant body ache; headahce; nausea; lightheaded/vertigo; lightheaded/vertigo; numbness in L cheek and tongue; numbness in L cheek and tongue; This is a spontaneous report from a non-contactable other-HCP. This Other-HCP reporting for a 35-years-old female patient. A 35-years-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 09Mar2021 09:45 as dose 2, single (at the age of 35-years-old) for covid-19 immunisation. The patient medical history included allergy to soy, corn, dust, cats. The patient concomitant medications included fish oil (OMEGA 3 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported and probiotics (PROBIOTICS) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 19Feb2021 at 10:00 (at the age of 35-years-old) as dose 1, single for covid-19 immunisation. The patient had not taken other vaccine in four weeks. The patient was not diagnosed with covid-19 prior to vaccination. Since vaccination, the patient has not been tested for covid-19. On 09Mar2021 at 13:00, the patient experienced 101.8 fever, significant body ache, headache, nausea, lightheaded/vertigo and numbness in l cheek and tongue. The patient did not receive any treatment for the events. The outcome of the events were recovering. No follow-up attempts are possible. No further information is obtained.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752274
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: extreme joint pain at times; heat; swelling; redness; can't sleep; Joint pain few in right hip and right thumb; This is a spontaneous report from a contactable consumer (patient). A 82-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date (age at vaccination: 82 years), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated she has been experiencing "bizarre" symptoms after getting the first dose of the Pfizer-BioNTech COVID-19 vaccine, since she has "never experienced this before". She specified she has "extreme joint pain at times" then the "swelling", the "redness" and the "heat" were "gone". She explained these joint pains were "continuous but not at the same level of discomfort". She listed the following different joint pain locations and mentioned different intensities for some at "Shoulder", which get "sore enough" that she "can't sleep", at "Few in [her] right hip", at "Right thumb", "One time [her] left foot had a reaction but is now back to normal", then " [her] right foot", and other area at a milder" intensity. She asked if her symptoms were reported as a side effect of the vaccine. The patient asked if she should get the second dose of the Pfizer-BioNTech COVID-19 vaccine given her reaction to the first. Outcome of the event extreme joint pain at times was not recovered, can't sleep and joint pain few in right hip and right thumb was unknown, and for all other events, it was recovered on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752275
Sex: M
Age:
State:

Vax Date: 03/06/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: rash that came on "all at one time" and seems to be anywhere, from: "under his arms, down his torso, on his stomach, down to his groin, and down his legs"; The rash goes from itchy to burning then progresses to pain; The rash goes from itchy to burning then progresses to pain; This is a spontaneous report from a contactable consumer (patient wife) via medical information department. A 70-year-old male patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration, on 06Mar2021 (Saturday), as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 10Mar2021, 4 days later Wednesday the patient develop rash all at one time and seems to be anywhere his clothes touch him from under his arms, down his torso, not as noticeable on his stomach, down to his groin, and down his legs. The rash was incredibly itchy, randomly getting worse. The rash goes from itchy to burning then progresses to pain. The urgent care prescribed steroids and antihistamines, Benadryl and Pepcid- not enough to keep him comfortable but neither seem to be helping to keep him comfortable. No other changes to lifestyle and have not been going out in public. The reporter queried should he take his second dose of vaccine and what recommendation to treat patient rash. Outcome of the events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1752276
Sex: F
Age:
State: VA

Vax Date: 03/06/2021
Onset Date: 03/06/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Redness; extreme pain; hot; hard size of a quarter at the injection site; fatigue; Diarrhea; fever; headaches; hot flash; chills; This is a spontaneous report from a contactable consumer. A 20-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: En6199) via an unspecified route of administration, administered in Arm Left on 06Mar2021 11:30 (age at vaccination 20-years-old) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On 06Mar2021 11:30 AM, patient experienced Redness, extreme pain, hot, and hard size of a quarter at the injection site, fatigue, Diarrhea, fever, headaches, hot flash, chills. No treatment was received for events. Patient has not taken any other vaccine with in four weeks and other medication in two weeks was Prescribed medicines. Patient has no known allergies reported. Patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and unknown if tested since the vaccination. Outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752277
Sex: F
Age:
State: MI

Vax Date: 01/29/2021
Onset Date: 02/02/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Blistered, itchy, raised rash to both forearms; Blistered, itchy, raised rash to both forearms; generalized body itching including scalp, face, neck, trunk, extremities; Eyelids moderately swollen; This is a spontaneous report from a contactable other hcp (Patient). A 55-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot Number: EL3248) via an unspecified route of administration (Age at vaccination 55-year) in left arm on 29Jan2021 at 11:00 AM as dose 2, single for COVID-19 immunization. Medical history included hypothyroidism, calcium citrate kidney stones, Mastcell Activation Disorder/Mastocytosis, Elevated Tryptase level, all from an unknown date and unknown if ongoing; history of allergic reactions to medications, On Montelukast and Levocetirizine allergy medications for Elevated Tryptase level vs. Mastcell Activation Disorder/Mastocytosis, hypothyroidism, calcium citrate kidney stones. Concomitant medications included levothyroxine sodium (SYNTHROID); hydrochlorothiazide; amiloride hcl; potassium; taken in two weeks of COVID-19 vaccination, for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (lot Number: EK9231) administered in left arm on 07Jan2021 at 04:00 PM for COVID-19 immunization. The patient previously took Mobic, Hydrocodone, Codeine, and experienced allergies. Reported facility type vaccine was hospital. The patient received no COVID prior vaccination. The patient not tested COVID post vaccination. The patient received no other vaccine in four weeks. On 02Feb2021 the patient experienced blistered, itchy, raised rash to both forearms; generalized body itching including scalp, face, neck, trunk, extremities; eyelids moderately swollen. AE resulted in doctor or other healthcare professional office/clinic visit. The patient received no treatment for the adverse events. The clinical outcome of the events was resolving. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752278
Sex: F
Age:
State: TX

Vax Date: 03/08/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210311; Test Name: covid; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Covid arm Red raised rash; Itchy; This is a spontaneous report from a contactable other hcp (Patient). A 42-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration (age at vaccination 42-year) in left arm on 08Mar2021 at 10:30 AM as dose 1, single for COVID-19 immunization. Medical history included autoimmune problems (since COVID), and COVID-19 (prior COVID vaccination), both from an unknown date and unknown if ongoing. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken in two weeks of COVID-19 vaccination, for an unspecified indication, start and stop date were not reported. The patient tested COVID post vaccination. The patient received no other vaccine in four weeks. The patient had no allergies reported. On 10Mar2021 the patient experienced COVID arm red raised rash, itchy. The patient underwent lab tests and procedures on 11Mar2021 which included SARS-COV-2 test: unknown results. The patient received no treatment for the adverse events. The clinical outcome of the events was not resolved. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752279
Sex: M
Age:
State: CT

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Arm sore; Joints (hips, knees & back) stiff and achy; Joints (hips, knees & back) stiff and achy; This is a spontaneous report from a non-contactable consumer (patient). A 71-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; expiry date-unknown; Batch/Lot Number: EN6202), via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 71-year-old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included asthma, high blood pressure and known allergies: Certain fruits. Concomitant medications included montelukast 10 mg; enalapril maleate 20mg 2x daily Am. No covid prior to vaccination. The patient experienced arm sore, joints (hips, knees & back) stiff and achy on 10Mar2021 18:30. No covid tested post vaccination. It was reported that Arm was still sore on the 2nd day. Joints (hips, knees & back) stiff and achy which started 6 or 7pm yesterday evening and continue to be achy today. No treatment received. The clinical outcome of the events was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752280
Sex: F
Age:
State: FL

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood tests; Result Unstructured Data: Test Result:unknown; Test Name: ct scan; Result Unstructured Data: Test Result:unknown; Test Name: EKG; Result Unstructured Data: Test Result:unknown; Test Date: 20210305; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Muscle pain; weakness in arms and legs; joint pain; restless legs; dizziness; brain fog; cold/numb hands and feet; sensitive to hot and cold; irritability; fatigue; cold/numb hands and feet; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EH9899, Expiry date: unknown) via an unspecified route of administration, administered in arm left on 28Jan2021 16:30 (at the age of 37 years) as dose 2, single for COVID-19 immunization (Hospital). Medical history included depression and anxiety. Concomitant medications included venlafaxine. The patient has no reported allergies. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EH9899, Expiry date: unknown) via an unspecified route of administration, administered in arm left on 07Jan2021 16:15 (at the age of 37 years) as dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 28Jan2021 21:30 the patient experienced muscle pain, weakness in arms and legs, joint pain, restless legs, dizziness, brain fog, cold/numb hands and feet, sensitive to hot and cold, irritability and fatigue. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Patient received treatment for the events. On 05Mar2021 the patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab): negative. Patient had no covid prior vaccination. The patient had no other vaccine in four weeks. On an unknown date patient underwent test procedure includes blood tests, ekg and ct scan with an unknown result. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is excepted.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752281
Sex: F
Age:
State: PA

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Temp; Result Unstructured Data: Test Result:101.7

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Body aches; 101.7 temp; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 08Mar2021 12:30 (Batch/Lot number and expiry date not reported) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was not reported. The patient was not pregnant at the time of vaccination. The patient was vaccinated at a public health clinic/veterans administration facility. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. Concomitant medications included sertraline taken for an unspecified indication, start and stop date were not reported; lisinopril taken for an unspecified indication, start and stop date were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route, left arm, on 15Feb2021 12:00 (at the age of 63 years) as dose 1, single for COVID-19 immunization. The patient experienced body aches on 09Mar2021 12:00 with outcome of recovered on Mar2021, 101.7 temp on 09Mar2021 12:00 with outcome of recovered on Mar2021, and fatigue on 09Mar2021 12:00 with outcome of recovered on Mar2021. The patient underwent lab tests and procedures which included body temperature: 101.7 on an unspecified date. No therapeutic measures were taken as a result of the events. The events were assessed as non-serious. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752282
Sex: M
Age:
State: CA

Vax Date: 02/17/2021
Onset Date: 02/21/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: severe rash on neck; burning sensation on skin; Itchy skin; This is a spontaneous report from a contactable consumer or other non-health care professional(patient). A 66-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL9262, Expiry date: unknown) via an unspecified route of administration, administered in Arm Right on 17Feb2021 09:30 (at the age of 66-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient had no known allergies. The patient had not received any other vaccine within 4 weeks. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID post vaccination. Medical history included Environmental allergies, hypothyroidism, sleep apnea. Concomitant medication in two weeks included sertraline (SERTRALINE), azelastine hydrochloride (ASTELIN [AZELASTINE HYDROCHLORIDE, diphenhydramine hydrochloride (BENADRYL) and Flonase (FLUTICASONE) taken for an unspecified indication, start and stop date were not reported. On 21Feb2021 18:15, Four days after first vaccine, the patient experienced severe rash on neck. Major symptom was burning sensation on skin and itchy skin. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6Z08, expiry date: not reported) via an unspecified route of administration, administered in Arm Right on 10Mar2021 as DOSE 2 SINGLE for COVID-19 immunization. Therapeutic measures steroid cream 2.5% was taken for the events. Adverse resulted in physician office visit. The outcome of the events was recovered in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752283
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Chills; Slight fever; very sore with swelling on the left arm; aching of the upper body; very sore with swelling on the left arm; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 63-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 10Mar2021 11:15 (at the age of 63-years-old) as dose 1, single for COVID-19 immunisation. Medical history included malaria (over 30 years ago) from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient was unaware of allergic reactions. It was reported that she was not a pregnant at the time of vaccination. She did not take any other vaccine in four weeks prior COVID -19 vaccine. She was not diagnosed with COVID prior vaccination and not tested with COVID post vaccination. On 11Mar2021 09:30 AM, the patient experienced chills, slight fever, very sore with swelling on the left arm and aching of the upper body. No therapeutic measures were taken. The outcome of events was recovering. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752284
Sex: F
Age:
State: NY

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: painful injection site; severe chills; fever; fatigue; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported), via an unspecified route of administration, administration on left arm on 15Feb2021 at 08:15 (at the age of 65-years-old) as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included COVID-19 on 10Jan2021 and was very sick for 12 days. The patient concomitant medications included acetaminophen. Patient had no known allergies Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 Since the vaccination. On 15Feb2021, the patient experienced painful injection site, severe chills, fever and fatigue. It was reported that, because she had COVID and she was sick, she decided to get the vaccine as soon as possible. She had first vaccine on 15Feb2021 and about 8 hours after vaccine began to have very painful injection site, as well as severe chills, fever and fatigue which resolved in 48 hours. Patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6203), via an unspecified route of administration, administration on left arm on 08Mar2021 at 08:15 (at the age of 65-year-old) as single dose for COVID-19 immunization and experienced adverse events. The outcome of the events was recovered on an unspecified date in Feb2021. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021273380 Same reporter,patient,product/ 2nd dose

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752285
Sex: F
Age:
State: CA

Vax Date: 03/04/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Rash with swelling; warm to the touch; red with a distinct line of rash; Rash with swelling; This is a spontaneous report from a contactable consumer (patient herself). A 29-years-old female patient non- pregnant received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6205), dose 1 via an unspecified route of administration, administered in Arm Left on 04Mar2021 at 14:30 (at the age of 29-years-old) as a DOSE 1, SINGLE for covid-19 immunisation at Public Health Clinic/Veterans Administration facility. The patient medical history included herpes virus infection and asthma both from an unknown date and unknown if ongoing. Other medications in two weeks were Birth control medications. The patient did not have any known allergies. Other vaccine in four weeks were none. Patient did not have covid prior vaccination was not tested for covid post vaccination. On 11Mar2021 at 20:00, patient experienced rash with swelling, warm to the touch and red with a distinct line of rash. No treatment was received for the events. Outcome of all the events were not recovered. No follow-up attempt is possible. No further information expected.

Other Meds:

Current Illness:

ID: 1752286
Sex: M
Age:
State: TX

Vax Date: 03/06/2021
Onset Date: 03/07/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: no strength to go to the restroom or get up out of the chair; ambled, weird gate.; Low grade fever; chills; Sweaty; This is a spontaneous report from a contactable consumer. This consumer reported for a 70-year-old male patient (Husband) that: A 70-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6205, Expiry Date: unknown), via an unspecified route of administration, administered in Arm Right on 06Mar2021 09:50 (at the age of 70 years old) as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included cardiac disorder from an unknown date and unknown if ongoing (Verbatim: hereditary heart disease), pacemaker (cardiac pacemaker insertion) from an unknown date and unknown if ongoing (Verbatim: pacemaker) , Bypass (vascular graft) from an unknown date and unknown if ongoing (from 20 years with Bypass 10 years ago), covid-19 from 2020 to 2020 (he had COVID 19 before on the 03Oct2020 through the middle of Nov2020 but is now fully recovered), blood thinner (blood disorder) from an unknown date and unknown if ongoing , sugar (blood glucose abnormal) from an unknown date and unknown if ongoing , prostate (prostate infection) from an unknown date and unknown if ongoing, acid reflux (gastrooesophageal reflux disease) from an unknown date and unknown if ongoing , heart/shrinks the heart (cardiac disorder) from an unknown date and unknown if ongoing, blood cholesterol from an unknown date and unknown if ongoing. It was reported that History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior Vaccinations (within 4 weeks) was no. Family Medical History was no.The patient experienced low grade fever, chills, sweaty on 07Mar2021, no strength to go to the restroom or get up out of the chair, ambled, weird gate. on 09Mar2021. He stated By Sunday patient was sick with low grade fever; chills; then by Tuesday had no strength to go to the restroom or get up out of the chair; and caller had to take him to the emergency room on Wednesday because it lasted more than a day. They were told these were symptoms of the vaccine and they were sent back home. The patient was not admitted to the hospital. Adds on Tuesday also noticed when caller helped him get up and patient just kind of ambled, it was weird a gate. Adds they expected his symptoms to get better and finally when caller took him to the emergency room on 09Mar2021, patient was so weak, caller couldn't get him out of the chair or go to the restroom. She Mentioned patient had COVID 19 before on the 03Oct2020 through the middle of Nov2020 but was now fully recovered. Adds even with COVID 19 it never was this debilitating. Caller clarified patient goes between chills and being hot and sweaty when patient breaks the fever. Patient gets a fever or 99 or 98 then breaks the sweat when the fever was done. Adds when patient did not cold patient was hot and sweaty and had to change clothes. He stated all the doctor's had told him the second dose was worse than the first. Patient was scheduled 27Mar2021 at 10:30 to get the second dose but was going to consult HCP first and do whatever he recommends. He stated just thought someone should know that these symptoms can last longer than a day or two.It was reported that Investigation Assessment was No. The patient went to the emergency room but not admitted. Relevant test were none. The outcome of event Low grade fever, no strength to go to the restroom or get up out of the chair was not recovered for event chills, Sweaty, ambled, weird gate outcome were recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752287
Sex: M
Age:
State: CT

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202103; Test Name: fever; Result Unstructured Data: Test Result:fever of 101; Test Date: 202103; Test Name: fever; Result Unstructured Data: Test Result:this morning it is 98.1

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Fever; Headache; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EP7535) via an unspecified route of administration, administered in Arm Right on 09Mar2021 13:30 (at the age of 68 years old) as dose 2, single for COVID-19 immunisation. Patient's Medical History (including any illness at time of vaccination) was none. Family medical history included breast cancer from an unknown date and unknown if ongoing (Mother had breast Cancer), heart condition from an unknown date and unknown if ongoing (father had a heart condition). Concomitant medication(s) included rivaroxaban (XARELTO) taken as blood thinner, start and stop date were not reported; spironolactone (SPIRONOLACTONE) taken for heart, start and stop date were not reported; digoxin (DIGOXIN) taken for an unspecified indication, start and stop date were not reported; olmesartan medoxomil (OLMESARTAN MEDOXOMIL) taken for cardiac for Atrial fibrillation, start and stop date were not reported; metoprolol (METOPROLOL) taken for an unspecified indication, start and stop date were not reported; magnesium (MAGNESIUM) taken for maintenance of magnesium, start and stop date were not reported; levothyroxine (LEVOTHYROXINE) taken for hypothyroidism, start and stop date were not reported; atorvastatin (ATORVASTATIN) taken for blood cholesterol, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6201) via an unspecified route of administration, administered in Arm Right on 16Feb2021 13:40 (at the age of 68 years old) as single for COVID-19 immunisation. The patient experienced fever, headache on 10Mar2021. Reported as, He got the second shot on Tuesday. For the first time throughout the whole Covid thing, mentions he takes his temperature every day, last night he had a fever of 101 and now this morning it is 98.1. He was asking if this normal. Adds he never gets fevers. Clarifies he received the first dose of the Pfizer Covid-19 vaccine on 16Feb2021 at 13:40p.m. in the right arm. He didn't have any effects not even a sore arm. And received the second dose 09Mar2021 at 13:30p.m. in right arm. Mentions he had someone drive him as he was worried he would have a reaction. He did not have a temperature on Tuesday when he got it but Wednesday night he got a headache which was not unusual; he touched his head and felt warm so he took his temperature with the ear thermometer and it said 101 Fahrenheit; and tried it again and it was 100.8. Adds that thing seems to run high but the one under his tongue was 100.4. The patient underwent lab tests and procedures which included pyrexia: fever of 101 on Mar2021, pyrexia: this morning it is 98.1 on Mar2021. Outcome of the event fever was recovered on 11Mar2021 and for headache recovered on 10Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752288
Sex: M
Age:
State: NC

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: dizziness; restricted breathing; heart palpitations along with occasional flush feeling; heart palpitations along with occasional flush feeling; very fatigued; This is a spontaneous report from a contactable consumer (patient). A 49-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 10Mar2021 at 10:45 (at the age of 49-years-old) as dose 1, single for COVID-19 immunization. Medical history included blood cholesterol increased from an unknown date and unknown if ongoing. Concomitant medication(s) included acetylsalicylic acid (ASPIRIN 81), pravastatin and tadalafil taken for an unspecified indication, start and stop date were not reported. The patient previously took lipitor [atorvastatin] and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient reported that shortly after receiving the shot, 10 Mar2021 11:00, patient experienced dizziness, restricted breathing and heart palpitations along with occasional flush feeling also very fatigued (10Mar2021) and that fatigue continued the next day (today, 11Mar2021). The patient did not receive any treatment. The clinical outcome for the events was recovering except not recovered for very fatigued. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds: Pfizer, Inc. 027034; Pfizer, Inc. 027034; Pfizer, Inc. 027034

Current Illness:

ID: 1752289
Sex: F
Age:
State: TX

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210305; Test Name: Fever; Result Unstructured Data: Test Result:102.2

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: chills; fever/102.2 fever; head and body aches began around midnight; head and body aches began around midnight; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 67-year-old female patient received bnt162b2 (Comirnaty, Solution for injection, Batch/Lot number: EN6202, expiry date: not reported, Age at vaccination: 67-year-old) via an unspecified route of administration in Left arm on 05Mar2021 09:30 AM as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included Synthroid, Singulair, Ambien. Historical vaccine included bnt162b2 for COVID-19 immunisation. On 05Mar2021 11:30 PM, patient experienced chills, fever, head and body aches. No other vaccine in four weeks. No treatment received for adverse event. No covid prior vaccination. No covid tested post vaccination. No known allergies. Lab test included Fever: 102.2 on 05Mar2021. The outcome of events was recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752290
Sex: F
Age:
State: KY

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210310; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: joint pain; fatigue; low fever; diarrhea; slight runny nose; muscle pain; This is a Spontaneous report from a Contactable Pharmacist. This 62-year-old female Pharmacist reported for herself that: A 62-year-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL9267), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:15 (at the age of 62 years old) as SINGLE DOSE for covid-19 immunisation. Medical history included myofascial pain (Myofascial pain syndrome) from an unknown date and unknown if ongoing, shoulder impingement (rotator cuff syndrome) from an unknown date and unknown if ongoing, atrial fibrillation from an unknown date and unknown if ongoing , spinal fusion surgery from an unknown date and unknown if ongoing. Concomitant medication(s) included Multaq (dronedarone hydrochloride) taken for an unspecified indication, start and stop date were not reported; Eliquis (Apixaban) taken for an unspecified indication, start and stop date were not reported; Protonix (Omeprazole) taken for an unspecified indication, start and stop date were not reported; Digoxin (Digoxin) taken for an unspecified indication, start and stop date were not reported; Biotin (Biotin) taken for an unspecified indication, start and stop date were not reported. It was reported that no other vaccine administered in four weeks. Covid prior to vaccination was no. Covid tested post vaccination was yes. Patient had no known allergies. The patient experienced joint pain, fatigue, low fever, diarrhea, slight runny nose, muscle pain on 23Feb2021 23:00. The patient underwent lab tests and procedures which included Nasal Swab (sars-cov-2 antibody test negative): negative on 10Mar2021. Therapeutic measure were taken as unknown as a result of event. The outcome of events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752291
Sex: F
Age:
State: NY

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210308; Test Name: chest feels like it was beating a little fast; Result Unstructured Data: Test Result:increased; Test Name: COVID-19 test; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Itching; Headaches; pain all over; chest feels like it was beating a little fast; Tired; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6206, Expiration date was not reported), via an unspecified route of administration in arm left (upper left arm) on 08Mar2021 at 11:15 (at the age of 65-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history included fibromyalgia, arthritis and acid reflux, known allergies: lactose, known allergies: penicillin and COVID-19. Past drug event included Cefaclor and experienced Known allergies: Cefaclor and Erythromycin and experienced Known allergies. The patient's concomitant medications in two weeks included lansoprazole (PREVACID), dexamethasone, tobramycin (TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION), both were taken for an unspecified indication. It was reported that, the patient was not pregnant at time of vaccination. No other vaccine in four weeks. The patient was diagnosed with covid prior vaccination and covid tested post vaccination was reported as yes. On 08Mar2021 at 13:00, the patient experienced Itching, headaches, pain all over, chest feels like it was beating a little fast, tired. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment medications included Benadryl, Tylenol. On an unspecified date, the patient underwent lab test and procedures which included COVID-19 test (SARS-CoV-2 test), resulted as unknown results and chest feels like it was beating a little fast (heart rate), resulted as increased on 08Mar2021. The outcome of the events was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752292
Sex: F
Age:
State: NY

Vax Date: 03/07/2021
Onset Date: 03/08/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Cough; Shortness of breath (except at rest); Fever; Chills; Weakness; Tiredness; Pain in vaccinated arm; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Red blotches/soreness on front of upper arm and shoulder; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 67-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number EN6203), via an unspecified route of administration, in Left arm on 07Mar2021 05:00 PM (at the of 67 years old) as dose 2, single for COVID-19 immunization. Medical history included cancer survivor with ongoing maintenance. Concomitant medications included trastuzumab (HERCEPTIN), carvedilol (CARVEDILOL), valsartan (VALSARTAN) taken in two weeks. Patient had no known allergies. Patient was not tested positive for COVID post vaccination and patient not had COVID prior vaccination. patient had not received any other vaccine in four weeks. Patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot number EL9266), via an unspecified route of administration, in Left arm on 14Feb2021 05:15 PM as dose 1, single for COVID-19 immunization. On 08Mar2021 07:00 AM the patient experienced Fever, chills, weakness, tiredness, pain in vaccinated arm with red blotches/soreness on front of upper arm and shoulder, cough, shortness of breath (except at rest), dizziness. Patient had not received any treatment for events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Cancer.

ID: 1752293
Sex: F
Age:
State:

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: headache; fatigued; shortness of breath; very thirsty; clammy; my eyes were very dry; heart palpitations; feeling similar to heart burn; feeling of heat (not quite burning) in upper arm; tingling of throat and tongue; tingling of throat and tongue; mild shivers; feel of coldness on my chest; This is a spontaneous report from a non-contactable consumer or Non-healthcare Professional (patient). A 33-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, in left arm on 11Mar2021 01:45 PM (at the age of 33 years old) as dose 1, single for COVID-19 immunization. Medical history included cardiac murmur (has never effected) , childhood asthma (outgrown) , gastrointestinal pain (sporadic and painful upset colon) psoriasis with beginning stages arthritis (not yet diagnosed as psoriatic arthritis), variant (methylenetetrahydrofolate reductase gene mutation), pre-hypertensive. I am on no medications. The patient's concomitant medications were not reported. Patient is not allergic. Patient was not tested positive for post vaccination and not had COVID prior to vaccination. Patient did not receive any other vaccine in last 4 weeks and any other medication in last 2 weeks. On 11Mar2021 the patient experienced starting to get a headache at 15:45 (2 hours later), tingling of throat and tongue at 13:50, mild shivers at 13:50, feel of coldness on her chest at 13:50, feeling of heat in upper arm at 13:55, heart palpitations at 14:00 (15 minutes), feeling similar to heart burn at 14:00 (15 minutes), patient eyes were very dry at 14:45 (1 hr), fatigued at 15:45 (2 hours later), shortness of breath at 15:45 (2 hours later), very thirsty at 15:45 (2 hours later), clammy at 15:45 (2 hours later), warm clammy palms, elbows, and armpits (10 minutes). It was reported that patient had effort required to swallow saliva (clear my throat), NO difficulty breathing The patient did not receive any treatment for adverse events and outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752294
Sex: F
Age:
State: MI

Vax Date: 02/05/2021
Onset Date: 02/12/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Rash on arm after 2nd dose; This is a spontaneous report from a contactable consumer (Patient herself). A 43-year-old non pregnant female patient received bnt162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Em9810), dose 2 via an unspecified route of administration, administered in Arm Left on 05Feb2021 as dose 2, single (at the age of 43-year-old) for COVID-19 immunisation. The patient received first dose of bnt162b2 on 14Jan2021 at 02.00 PM (lot number El3249, Administration date 14Jan2021 at 02:00 PM, administered in right arm) (at the age of 43-year-old) for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included Pituitary tumor, diabetes and known allergies from an unknown date and unknown if ongoing. The patient did not have covid prior vaccination. Concomitant medications included in two weeks semaglutide (OZEMPIC) and sitagliptin phosphate (JANUVIA). The patient did not receive any other vaccine in four weeks. The patient experienced rash on arm after 2nd dose on 12Feb2021. The events resulted in physician office visit. The patient not tested for covid post vaccination. Therapeutic measures were taken as a result of rash on arm after 2nd dose and treatment included with Benadryl, cortisone cream. The outcome of event reported as recovered on an unknown date of 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752295
Sex: M
Age:
State: NY

Vax Date: 03/03/2021
Onset Date: 03/06/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210306; Test Name: fever; Result Unstructured Data: Test Result:High; Test Date: 20210307; Test Name: fever; Result Unstructured Data: Test Result:104; Comments: High fever peaked Sunday at 104.

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Dizzy; no appetite; feel like garbage; high fever; Chills; This is a spontaneous report from a contactable consumer or other non hcp. A 35-years-old male patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6202; Expiration Date: 30Jun2021), via an unspecified route of administration, administered in Arm Left on 03Mar2021 13:30 as 1st dose, single for covid-19 immunisation. (Age at vaccination was 35years). Medical history and concomitant medications were not reported. The patient experienced high fever, chills on 06Mar2021, dizzy on 07Mar2021, no appetite on 06Mar2021, feel like garbage. The patient underwent lab tests and procedures which included body temperature: high on 06Mar2021, body temperature: 104 on 07Mar2021 High fever peaked Sunday at 104. Therapeutic measures were taken as a result of high fever. Patient feels a little tiny bit better each day, but it is cyclical through the day. Looked online, says side effects are worse for the second dose. So, he doesn't even know where to go for the information. Patient details about this morning had it 250 but usually it's between 250-260, somewhere in there, at least it was last week, but he hasn't eaten very much. Often when patient gets the regular flu shot, he feels a little crappy the next day, under the weather. Emergency room visit was no, physician office visit was no, prior vaccinations (within 4 weeks) was none.AE(S) following prior vaccinations was only the flu vaccine, caller does not have NDC, lot number, and expiration date to provide. Adverse event: under the weather, feel a little crappy the next day. Patient's medical history (including any illness at time of vaccination was none. Family medical history relevant to AE(s) was none. Relevant tests: none. Yes, there a Product Complaint. Description of complaint patient is a consumer reporting his experience with Pfizer Covid-19 Vaccine. He states he has high fever. He states he has been diligent about Advil and Tylenol and when he doesn't take them the fever comes back but it's getting better little by little. No further information provided. Outcome of the events for high fever was recovering, chills was recovered, dizzy, no appetite not recovered, feel like garbage was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752296
Sex: F
Age:
State: AL

Vax Date: 02/20/2021
Onset Date: 02/21/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210221; Test Name: temperature; Result Unstructured Data: Test Result:100; Comments: low grade temperature; Test Date: 20210302; Test Name: covid-19 test; Test Result: Negative ; Comments: Nasal Swab Covid test name post vaccination=Rapid test; Test Date: 20210302; Test Name: covid-19 test; Test Result: Negative ; Comments: Nasal Swab Covid test name post vaccination=PCR; Test Date: 20210304; Test Name: covid-19 test; Test Result: Negative ; Comments: Nasal Swab Covid test name post vaccination=Rapid test; Test Date: 20210304; Test Name: covid-19 test; Test Result: Negative ; Comments: Nasal Swab Covid test name post vaccination=PCR

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: severe fatigue; headache; joint pain; nausea; vomiting; chills; sweats; low grade temp 100; This is a spontaneous report from a contactable other healthcare professional (patient). A 47-year-old adult female patient (Non pregnant) received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot/batch number and expiry date were not reported), via an unspecified route of administration at left arm, on 20Feb2021 at 06:30 PM (age at vaccination: 47 years), as a dose 1, single for COVID-19 immunization. The patient's medical history includes controlled high blood pressure. Patient was allergy to Cephalosporin and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient concomitant medication included Amlodipine 5mg daily. 24 hours after getting vaccine, On 21Feb2021 05:30 PM, the patient had experienced severe fatigue, headache, joint pain, nausea and vomiting, chills, sweats and low grade temp 100-symptoms still present. On 02Mar2021, the patient had laboratory investigations on nasal swab rapid test and nasal swab PCR which test results negative. On 04Mar2021, the patient had nasal swab rapid test and nasal swab PCR test result negative. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was tested for COVID-19. At the time of reporting, the outcome of the events were not recovered. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds: Pfizer, Inc. 027034

Current Illness:

ID: 1752297
Sex: F
Age:
State: GA

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: This is a spontaneous report from a contactable consumer (patient herself). A 56-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EN6205, Expiry date, NDC number, UPC number was not reported), via an unspecified route of administration, administered in Arm Right on 11Mar2021 (Age at vaccination 56-years-old) as dose 1, single for covid-19 immunisation. Medical history included blood pressure high from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not pregnant at time of vaccination. The patient had no known allergies. Caller stated, she states that she is having problems with symptoms related to the Covid 19 vaccine. She states that she feels like something pulsating though her, body discomfort, slight headache, her hands are cold. Clarifies her discomfort is from her neck all the way down to her feet. States when she moves, she is even more uncomfortable. On 11Mar2021, yesterday was her vaccine and later that night she experienced a bump, if she can call it that, it was red and had what looked like had a dash in the middle of it, very red. She states that she is calling to report her symptoms and she would like to have something to relieve them. PSCC Communication: Call handler apologized for symptoms and advised called that her physician would be the best person to contact regarding appropriate treatment options for her symptoms. Caller handler states that she would like to ask her some additional questions about her symptoms for a report. Caller was unsatisfied with that option. Call handler notified caller that the Medical Information has resources that may be able to assist her with her question and that they have product specific resources, but we do not provide medical advice. Caller becomes more upset and states the following: She is very uncomfortable with Pfizer, she thought she would be able to take the vaccine and be aware of the side effects. States this is just a statistical analysis for the causes of the vaccine to be used as data. She states that she is so uncomfortable with that and she will tell everyone not to use Pfizer because of the complications and because of problem to alleviate the symptoms. She states that there is no information on the paper to alleviate the symptoms. They gave her a paper about what to expect but not what to do about it. She states it is like collecting data. She states she went online, with the hospital and all collecting data. States we are collecting data but not giving any relief. States that her advice would be to indicate on the information sheet that patients will be experiencing symptoms, but Pfizer is not in a medical position to assist you in giving you relief. Her advice is to provide a contact number or tell people to contact their PCP. States that she thinks people have the right to know that they will have side effects but there is nothing Pfizer can do. She states that she is very uncomfortable. She states that all Pfizer is doing it getting people and collecting data. She states that she feels like a guinea pig. States across the world age and time but that is all they need to put in the little old computer. States the scientist will come out with information and the public has the right to know. She states that she is in pain all over her body, not justified. States 96% efficacy, that is good, however, there needs to be some help. Caller provided with Report Reference. Consumer stated, it doesn't have an expiration date. Consumer stated What is the next process in order to help me to relieve the discomfort I am feeling, you are asking questions, but you are not telling me what to do. Consumer stated, I took the Pfizer vaccine (Unspecified Vaccine) on yesterday and last night my forearm, I took the vaccine on my right arm and last night a bump appeared on my lower portion of my arm and it was red and not huge, but it was a bump, and it was red in the middle of it and it spread out, currently I am feeling discomfort to my neck to my feet it feels like something frustrating to my body and my hands are cold. The caller stated she is having side effects from the first vaccine. Yesterday, about 3 hours after the vaccine, she had injection discomfort but received a red, round spot at the injection site with what looked like a slit inside. She is having muscle uncomfortableness from her neck down to her feet. When she moves it hurts, it is painful but a pain of 3 from 1-5. She has a headache at the front part of her brain and the lower part at the cervical area. She asked, how does she relieve the symptoms to be able to function more effectively. The caller stated she wanted to make a comment: Pfizer has promoted the vaccine as being 96% efficacy and state the symptoms that you may experience, but they do not indicate how to get assistance in relieving the side effects. They should indicate that on their information packet, without going through the steps I have gone through and the frustration and let them know that Pfizer cannot provide information on treatment and let people know to contact the physician. Everyone I talked to is collecting data. I am uncomfortable that I feel like a Guinea pig and Pfizer is not trying to help individuals and only trying to determine information on how this drug is working. I think it should be noted. I have been in queue forever...I spoke with 5 agents in 2 hours. Anyone I talk to I would refer them not to use Pfizer, the purpose of a pharmaceutical company is to make a drug and place it on the market. They are not into relieving the pain. They are in it to make money and they do not provide any information in between. They do not contact the CDC so people are going round and round and round and all they are doing is giving data for Pfizer so they can recompound their drug to make it better. I am uncomfortable for being used just to make the drug better for Pfizer to make more money. Bring some scientist in to discuss the side effects before they put things on the market. The patient did not receive treatment for the adverse event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of events pain over entire body. It feels like the drug is traveling throughout my body was not recovered and rest of the events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1752298
Sex: F
Age:
State: TN

Vax Date: 02/26/2021
Onset Date: 03/06/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210304; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: rash on back and side; Large red itchy bumps; bumps are sore with a little pain; This is a spontaneous report from a contactable consumer or other non hcp. A 63-years-old non- pregnant female patient received bnt162b2 (BNT162B2) formulation solution for injection, dose 2 (Lot Number: EN5318 expiry date was unknown) via an unspecified route of administration at arm Left on 26Feb2021 13:45 (at the age of 63-years-old) as a single dose for covid-19 immunisation. Medical history included hiv infection from an unknown date and unknown if ongoing HIV undetected viral load, hypertension from an unknown date and unknown if ongoing High blood pressure. The patient previously took codeine and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. Patient had known allergies with Codeine. Historical vaccine dose 1 (Lot Number: EN518 expiry date was unknown) via unspecified route of administration at arm right on 29-JAN-2021 as a single for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.Other medications in two weeks: Same maintenance medications as before first shot. On 06Mar2021 rash on back and side. Large red itchy bumps that have fluid inside. The risings vary in size. The largest bump was the size of a dime that has burst and has a black scab. The other bumps are in a line along her waist and are approximately 1/4 of a dime. There was also a bump on her ear. The bumps are sore with a little pain. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 04Mar2021. No treatment was given for adverse events. Outcome of the events was on rash was unknown and other events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752299
Sex: M
Age:
State: PA

Vax Date: 03/08/2021
Onset Date: 03/09/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210309; Test Name: Fever; Result Unstructured Data: Test Result:104 Fahrenheit; Comments: 104 F

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Fever 104 F; Muscle aches-whole body; Chills; Nausea; Chest tightness; Dizziness; This is a spontaneous report from a contactable consumer. This 58-year-old male consumer (Patient) reported. A 58-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EN6204), dose 1 via an unspecified route of administration, administered in Arm Left on 08Mar2021 16:45 (at the age of 58-years-old) as a single dose for covid-19 immunization. Medical history included type 2 diabetes mellitus, hypertension, haemochromatosis. Concomitant medication(s) medications in two weeks included insulin glargine (TOUJEO); losartan potassium; gabapentin; metformin; fenofibric acid. The patient did not have any allergies. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Mar2021 15:00, the patient experienced fever 104 F, muscle aches-whole body, chills, nausea, chest tightness, dizziness. The patient did not receive any treatment. Outcome of the event was recovering, at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752300
Sex: F
Age:
State:

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: antibody test; Result Unstructured Data: Test Result: negative; Comments: they pricked her finger and said she had no antibodies (negative IgC and IgM).

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: chills; felt like someone punched me in the back; low grade fever; pain when I would breath; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route on 17Feb2021 (12 days past the 21 days) as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) as a single dose for covid-19 immunization and her arm was sore. On an unknown date, patient experienced chills, felt like someone punched her in the back, had low grade fever, and had pain when she would breathe. She had no antibodies when they checked. She got an antibody test they pricked her finger and said she had no antibodies (negative IgC and IgM). They advised her to come back in 1 month to test again. The patient underwent lab test and procedure, which included antibody test they pricked her finger and said she had no antibodies (negative IgC and IgM). The clinical outcome of the events was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752301
Sex: F
Age:
State: OH

Vax Date: 03/02/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: red deltoid muscle just below injection site; Swollen; sore; somewhat itchy; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 62-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6202), via an unspecified route of administration (at the age of 62-years), administered in arm left on 02Mar2021 at 17:30 as dose 1, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medica-tions included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfeta-mine sulfate (ADDERALL) taken as 30mg, sertraline hydrochloride (ZOLOFT), clonazepam (KLONOPIN), zinc (ZINC), colecalciferol (D) taken for an unspecified indication, start and stop date were not report-ed. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and has not been tested for covid post vaccination. The vaccination facility type was reported as other. The patient previously took opioids and experienced known allergies. On 11Mar2021 at 20:00, the patient experienced red deltoid muscle just below injection site, swollen, sore, somewhat itchy. The treatment was not received for all the adverse events. The clinical outcome for all the events was reported as not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752302
Sex: M
Age:
State: MN

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: This is a spontaneous report from a contactable other healthcare professional (patient himself). A 73-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# EN6206), at the age of 73, via an unspecified route of administration, right arm, on Mar 10, 2021, at 16:30, single dose, for COVID-19 immunization. Vaccination facility type: urgent care center. Patient did not receive other vaccine in four weeks or other medications in two weeks. Medical history and concomitant medications not reported. The patient did not have COVID-19 prior to vaccination. Patient was not COVID-19 tested post vaccination. Patient has no known allergies. Patient experienced moderate back/backache and joint pain on Mar 11, 2021. Reportedly, moderate back and joint pain evident the morning after vaccination (12 hours after vaccination).The pain manifested when moving and exercising, but not when motionless or sleeping/resting. The moderate back and joint pain was still present 36 hours after vaccination. The patient did not receive any treatment for the adverse events. The outcome of the events: not recovered. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1752303
Sex: F
Age:
State: CT

Vax Date: 03/04/2021
Onset Date: 03/04/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: After second dose my migraines have been severe.; arthritis pain in my hands has increased exponentially and I'm experiencing joint pain all over my body; Also experience serious fatigue; arthritis pain in my hands has increased exponentially and I'm experiencing joint pain all over my body; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6201) via an unspecified route of administration in left arm on 04Mar2021 as dose 2, single (at the age of 24-years-old) for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Patient medical history included anxiety, depression, arthritis. Also had mild arthritis, panic disorder. Patient was currently being treated for chronic migraine (migraine), panic disorder and major depressive disorder. Patient received unknown concomitant medications in last 2 weeks. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EM9808) via an unspecified route of administration in left arm on 11Feb2021 13:15 as dose 1, single for COVID-19 immunization and was severely depressed. The patient did not have Covid prior vaccination, did not have any other vaccine in four weeks, did not test covid post vaccination and did not have known allergies. It was reported that after the first administration she became severely depressed, but this could have been a result of outside factors. Had to change medications. After second dose on 04Mar2021 16:00 the patient experienced migraines had been severe for which she had been receiving treatment for them for over a year and now they were as bad as they were prior to starting treatment. On same day, the patient also experienced arthritis pain in her hands on 04Mar2021 16:00 which had increased exponentially, experiencing joint pain all over her body on 04Mar2021 14:00 and also serious fatigue on 04Mar2021 16:00. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752304
Sex: F
Age:
State: FL

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: hip is very sore; This is a spontaneous report from a contactable consumer (patient). A 64-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 11Mar2021 08:30 (at the age of 64-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Hospital. Medical history included arthritis, diabetes, known allergies of penicillin, hip replacement 8 years ago. Concomitant medications included yes, as prescribed (other medications in two weeks). No other vaccine in four weeks. No covid prior vaccination, no covid tested post vaccination. On 12Mar2021 08:00, the patient experienced hip was very sore morning after covid vaccine. There were no other injuries to this hip. No treatment received for event. Outcome of event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot been obtained.

Other Meds:

Current Illness:

ID: 1752305
Sex: F
Age:
State: FL

Vax Date: 03/03/2021
Onset Date: 03/03/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: chills; fever; tiredness; headache; nausea; This is a spontaneous report from a contactable consumer (patient). This 67-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration in arm left on 03Mar2021 at 10:00 am (age at vaccination 67 years) as dose 1, single dose for COVID-19 immunization. Medical history included asthma and HBP (high blood pressure). Patient was not pregnant at time of vaccination and received no other vaccine in four weeks. No COVID prior vaccination, no COVID tested post vaccination and no known allergies. Concomitant medications included losartan, sertraline, simvastatin and amitriptyline all were taken for an unspecified indication, start and stop date were not reported. It was reported that after receiving the dose of vaccine on 03Mar2021 at 21:00 pm, the patient experienced chills, fever, tiredness, headache and nausea. No treatment received for the events. The outcome of all the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752306
Sex: F
Age:
State: MN

Vax Date: 03/08/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Rash /Hives all over the body. Itchy for approximately 3 days.; Rash /Hives all over the body. Itchy for approximately 3 days.; Rash /Hives all over the body. Itchy for approximately 3 days.; This is a spontaneous report from a contactable consumer or other non hcp. A 64-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EP6955), dose 1 via an unspecified route of administration, administered in Arm Left on 08Mar2021 16:00 as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included type 1 diabetes mellitus from an unknown date and unknown if ongoing Type 1 Diabetes, sleep apnoea syndrome from an unknown date and unknown if ongoing Sleep Apnea, drug hypersensitivity sulfa from an unknown date and unknown if ongoing. Concomitant medications included insulin (INSULIN) taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at the time of vaccination. Patient did not receive other vaccine in four weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. The patient experienced rash /hives all over the body, itchy for approximately 3 days. On 10Mar2021 pruritus 20:00, rash /hives all over the body, itchy for approximately 3 days, rash, rash /hives all over the body, itchy for approximately 3 days, urticaria. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752307
Sex: M
Age:
State: ID

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: aching chest all the way across and down to my elbows on both arms; unable to sleep.; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 11Mar2021 08:45 (at the age of 67-year-old) as dose 2, single for COVID-19 immunisation at other facility. The patient medical history was not reported. Concomitant medication included atorvastatin taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunisation. The patient had no known allergies. The patient did not diagnose with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The evening of the vaccination date (11Mar2021 at 21:00), he had an aching chest all the way across and down to his elbows on both arms, was unable to sleep and was not head achy. Do not think he had a temperature. It was improving "this" morning. It was currently 23.5 hours after receiving his 2nd dose. The patient did not receive any treatment for the events. The outcome of the events was reported as resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752308
Sex: F
Age:
State: NC

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Vomit; chills; fever; body ache; exhaustion; headaches; This is a spontaneous report from a contactable consumer (patient). A 37-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6208, Expiry date: not reported), via an unspecified route of administration on 11Mar2021 (at the age of 37-years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medications included Melatonin, Polycarbophil calcium (FIBER), Multi vitamin and Hyde pre workout. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6203, Expiry date: not reported), via an unspecified route of administration on 18Feb2021 15:00 (at age of 36-years-old) as dose 1, single for covid-19 immunisation. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and post the vaccination, the patient was not tested for COVID-19. On 12Mar2021 at 12:00, the patient experienced vomit, chills, fever, body ache, exhaustion and headaches. Treatment for the adverse events was Theraflu. The outcome of all the events was reported as not recovered. No follow-up attempts were possible. No further information was expected.

Other Meds: Pfizer, Inc. 027034; Pfizer, Inc. 027034

Current Illness:

ID: 1752309
Sex: F
Age:
State: MI

Vax Date: 03/09/2021
Onset Date: 03/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body temperature; Result Unstructured Data: Test Result:102; Comments: Fever of 102.

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Fever of 102; chills; muscle aches; headache; brief loss of taste; insomnia; tenderness at the site of injection; This is a spontaneous report from a non-contactable consumer or other non healthcare professional. A 40 year old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 09Mar2021 07:15 (Batch/Lot Number: EL3248) as DOSE 2, SINGLE for covid-19 immunisation. Historical vaccine included bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 26Feb2021 (Batch/Lot Number: EL3248) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported and oral birth control. The patient experienced fever of 102 causing pyrexia on 10Mar2021 03:00 with outcome of recovered, chills on 10Mar2021 03:00 with outcome of recovered, muscle aches causing myalgia on 10Mar2021 03:00 with outcome of recovered, headache on 10Mar2021 03:00 with outcome of recovered, brief loss of taste causing ageusia on 10Mar2021 03:00 with outcome of recovered, insomnia on 10Mar2021 03:00 with outcome of recovered and tenderness at the site of injection causing injection site pain on 10Mar2021 03:00 with outcome of recovered. The patient underwent lab tests and procedures which included body temperature at 102. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752310
Sex: M
Age:
State: MI

Vax Date: 02/11/2021
Onset Date: 02/16/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: First dose: 11Feb2021 and Second dose: 03Apr2021; Sharp pain in thigh and calf; pain in hip jots; This is a spontaneous report from a contactable consumer (reported for himself). A 73-years-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9267/Batch number was not reported), dose 1 via an unspecified route of administration, administered in arm left on 11Feb2021 at 12:00 AM (at the age of 73-years-old) as dose 1, single and second dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 03Apr2021 (at the age of 73-years-old) as dose 2, single; both for covid-19 immunisation at other. Medical history included hypertension from an unknown date and unknown if ongoing and diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medication included metformin (METFORMIN) taken for blood pressure measurement, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. The consumer reported that, sharp pain in thigh and calf and pain in hip joints from week after first shot to one week after second shot 03Apr2021. No treatment was given for the events. The outcome of the events was resolved on an unspecified date in Apr2021. No follow up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752311
Sex: M
Age:
State: IL

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body Temperature; Result Unstructured Data: Test Result:100-101 degrees.

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Fever/Fever was at about 100-101 degrees; general soreness; This is a spontaneous report from a contactable consumer (patient). A 40-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 10Mar2021 15:45 (at the age of 40-years-old) as dose 2, single for COVID-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medications included hydrochlorothiazide, lisinopril (LISINOPRIL + HIDROCLOROTIAZIDA), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. Patient had no known allergies. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: Lot number: EN6201), via an unspecified route of administration, administered in Arm Left on 17Feb2021 03:45 PM as dose 1, single for COVID-19 immunisation. No other vaccine in four weeks. The patient did not tested covid prior vaccination and also not tested covid post vaccination. On 11Mar2021 07:00 AM the patient experienced fever about 100-101 degrees and general soreness. It was reported that events lasted about 30 hours after shot (about 9pm day after, (11Mar2021)). The patient underwent lab tests and procedures which included body temperature: 100-101 degrees. No therapeutic measures was taken. The outcome of events was recovered on 11Mar2021. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752312
Sex: F
Age:
State: CA

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: swelling and tenderness at injection site; swelling and tenderness at injection site; swelling of lymph nodes in armpit on the side of injection site; joint pain; headache; This is a spontaneous report from a contactable other health care professional (patient). A 31-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208) via an unspecified route of administration, administered in left arm on 10Mar2021 16:30 (at the age of 31-year-old) as single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included hypertension, anxiety and depression. Concomitant medications included sertraline, buspirone, lotensin and nortriptyline taken for an unspecified indication and start and stop date were not reported. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208) via an unspecified route of administration, administered in left arm on 17Feb2021 at 09:30 at single dose for COVID-19 immunisation. On 11Mar2021 at 10:00 AM, the patient experienced swelling and tenderness at injection site, swelling of lymph nodes in armpit on the side of injection site, joint pain and headache. Facility type vaccine was reported as Doctor office/urgent care. The patient did not receive treatment for the events. The clinical outcome of events was recovering at the time of report. No follow-up attempts are possible. No further information is expected

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752313
Sex: M
Age:
State: TX

Vax Date: 03/09/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull.; Severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull.; This is a spontaneous report from a contactable consumer (patient). A 74-years-old male patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EN6198), via an unknown route of administration in right arm on 09Mar2021 at 10:00 (at the age of 74-years-old) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. No known allergies. No other vaccine in four weeks. Yes, other medications in two weeks further not clarified. The patient received BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL9269), via an unknown route of administration in left arm on 07Feb2021 at 09:00 (at the age of 74-years-old) as historical vaccine dose 1, single for COVID-19 immunisation. On 11Mar2021 at 16:15, the patient experienced severe pain from right shoulder along upper back, up my neck to the bottom of my head. Pain continues up the back of my head to the top of the rear of my skull. No COVID prior vaccination. No COVID tested post vaccination. It was unknown if treatment received for events. The outcome of events was unknown. No Follow up attempts are possible. No further information is excepted.

Other Meds:

Current Illness:

ID: 1752314
Sex: F
Age:
State: NY

Vax Date: 03/11/2021
Onset Date: 03/12/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: I am in so much pain, with aches and joints/ Every joint is killing me.; My legs are throbbing; I am in so much pain, with aches and joints/ Every joint is killing me.; My back, I can't get comfortable; The arm that I got the shot is so sore; The arm that I got the shot is so sore; This is a spontaneous report from a contactable Other HCP (patient). A non-pregnant 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not reported, expiry date: not reported, Age at vaccination: 51-year-old) via an unspecified route of administration in left arm on 11Mar2021 01:00 PM as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was included overweight, borderline diabetic. Concomitant medications included Clodian, omeprazole, venlafaxine. Historical vaccine included bnt162b2 via an unspecified route of administration in left arm on 19Feb2021 as Dose 1, SINGLE for COVID-19 immunization. On 12Mar2021 02:00 AM, patient experienced i am in so much pain, with aches and joints/ Every joint is killing me (joint pain and pain), my legs are throbbing, my back, I can't get comfortable, the arm that I got the shot is so sore (vaccination site pain and pain in arm). Facility type vaccine was workplace clinic. Treatment was received for the adverse event as Aleve. No covid prior vaccination. Covid was not tested post vaccination. No known allergies. The outcome of events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1752315
Sex: F
Age:
State: NY

Vax Date: 03/07/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: I had a flare up of symptoms that have previously been diagnosed as psoriasis or maybe an allergic reaction; eyes swelled up and the skin around them became red, scaly and painful; eyes swelled up and the skin around them became red, scaly and painful; eyes swelled up and the skin around them became red, scaly and painful; This is a spontaneous report received from a contactable consumer or other non hcp. A 46-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: En6205) via an unspecified route of administration in Arm Left on 07Mar2021 16:00 (age at vaccination 46years old) as single dose for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not have Known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient medical history was not reported. Concomitant medication(s) included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested positive for COVID-19. On 11Mar2021 at 04:00 the patient experienced i had a flare up of symptoms that have previously been diagnosed as psoriasis or maybe an allergic reaction, eyes swelled up and the skin around them became red, scaly and painful. Clinical course was reported as she had a flare up of symptoms that has previously been diagnosed as psoriasis or maybe an allergic reaction. she has never known for sure what it is. But 4 days after her first dose, her eyes swelled up and the skin around them became red, scaly, and painful. This has happened in the past and has never been definitively diagnosed. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752316
Sex: F
Age:
State: NJ

Vax Date: 02/16/2021
Onset Date: 02/16/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: dry skin; itching; rash all over on both legs; This is a spontaneous report from a contactable consumer. This 74 year old female consumer reported that: A 74-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection,Lot number: EL9266, Expiry Date: 31May2021), via an unspecified route of administration, administered in Arm Left on 16Feb2021 12:30 (at the age of 74 years old) as first dose, SINGLE for covid-19 immunisation. Medical history included blood pressure measurement from an unknown date and unknown if ongoing (Verbatim: blood pressure, controlled by medications), blood cholesterol from an unknown date and unknown if ongoing (Verbatim: cholesterol, controlled by medications). It was reported that Prior Vaccinations (within 4 weeks) was no, Adverse event following prior vaccinations was no. Patients Medical History (including any illness at time of vaccination) was no. It was reported that History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional Administered Vaccines If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect was no.The patient experienced rash all over on both legs on 16Feb2021 and it's still a little bit there, dry skin, itching on an unspecified date. She did not file a report for an adverse event with the first Covid 19 vaccine. She stated an came over and looked at her legs and they weren't sure she should got the second Covid 19 vaccine. That was at the (withheld) mega site for vaccines. She had a picture of the rash. They looked at her legs and there were still a few welts. Patient stated that night in bed was when caller felt itching. Clarified as the day she received the first Covid 19 vaccine on 16Feb2021. Caller received the vaccine at 12:30 in the afternoon. She was scratching in bed, she had dry skin and she thought it was dry skin. She took a jacuzzi bath in the mornings and the rash showed more with the heat of the water. Caller stated there were still a few welts, it looked like measles but it had welts. She did have a shingles vaccine. She had her second shingles vaccine 5 weeks before she received her first Covid 19 vaccine. She had gone to see one of her doctor's associates and he said to take some Benadryl and that should clear it up. Then someone else had a rash and they used Benadryl spray. the rash is about 10% of what it was but were still there. The rash started at her ankles and traveled up to her thighs. She knows people who had passed from Covid 19 and she did not want to be one of them. She wanted to be vaccinated and feel safe. She fell in the fall and she had been doctoring that. When querying if she had been to a physician she reported she had an appointment and it was a coincidence and while she was there she showed the doctor her legs. Caller was not diagnosed with shingles while at the doctor. When querying NDC, LOT, Expiry for Benadryl caller stated the print was small, her glasses correct her vision but this was small. She was taking the box to more light to see. She was having to use a magnifying glass to read the print. Injection did not hurt, her arm was fine. It was reported that Emergency Room was no, and visit to Physician Office was yes. The patient was not hospitalized.It was reported that relevant test was no. Therapeutic measures were taken with Benadryl tablets, Lot SBC110, expiration Jul2021: 25mg ,1 tablet probably 2-3 times a day. She took two when she thought her rash was better. Benadryl spray, the pharmacist in (withheld) told her it was the same as Benadryl, Itch Relief Spray; Lot R200530, Expiration Jul2022, topical use. The spray is diphenhydramine hcl 2% then zinc acetate 0.1% as a result of rash all over on both legs, dry skin, itching. It was reported that there was a Product Complaint. Description of Product Complaint:Description of complaint: Print on Benadryl too small to see the NDC/Lot/Expiry. Benadryl tablets 25mg ,1 tablet probably 2-3 times a day. She took two when she thought her rash was better. Benadryl spray, the pharmacist in (withheld) told her it was the same as Benadryl, Itch Relief Spray, topical use. The spray is diphenhydramine hcl 2% then zinc acetate 0.1% She is using a magnifying glass. States it is unbelievable they do not want you to see these things when querying lot and expiration date. Benadryl tablets Lot SBC110 expiration Jul2021.Itch Relief Spray Lot R200530 Expiration Jul2022. The outcome of event rash all over on both legs was recovering, for event dry skin, itching outcome was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021273866 similar report from same reporter

Other Meds: Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034; Pfizer, Inc. EUA 027034

Current Illness:

ID: 1752317
Sex: F
Age:
State: WI

Vax Date: 01/27/2021
Onset Date: 02/10/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: red blotchy rash and itching on face; red blotchy rash and itching on face; This is a spontaneous report from a contactable consumer or other non hcp. An 69-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL3248), dose 1 via an unspecified route of administration, administered in Arm Left on 27Jan2021 10:30 as 1ST DOSE, SINGLE for covid-19 immunisation. Patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN5318), dose 1 via an unspecified route of administration, administered in Arm Left on 17Feb2021 as 2 nd dose DOSE, SINGLE for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. Concomitant medications included fenofibrate (FENOFIBRATE) taken for an unspecified indication, start and stop date were not reported; levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported; colecalciferol (D3) taken for an unspecified indication, start and stop date were not reported; iron (IRON) taken for an unspecified indication, start and stop date were not reported. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive other medications in two weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. The patient previously took amoxicillin and experienced drug hypersensitivity, oxycodone, and experienced drug hypersensitivity. The patient experienced red blotchy rash and itching on face on 10Feb2021, red blotchy rash and itching on face on 10Feb2021. Therapeutic measures were taken as a result of red blotchy rash and itching on face, red blotchy rash and itching on face. Exactly 2 weeks after 1st shot got a red blotchy rash and itching on face. Took benadryl for 2 days then Claritin for 2 days and it cleared up. Then exactly 2 weeks after 2nd shot got same rash and itching. Took Benadryl again for 2 days and claritin for 2 days and again it cleared up. The outcome of the events were recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752318
Sex: F
Age:
State: NJ

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: chills; low grade fever; headache; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 56-years-old non pregnant female patient received (not pregnant at the time of vaccination) bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 2 via an unspecified route of administration, administered in arm left on 10Mar2021 11:00 (Batch/Lot Number: EN6206) as dose 2, single for covid-19 immunisation (at the age of 56-year-old). The patient medical history was reported as none. The concomitant medication(s) included vitamin d (VITAMIN D NOS) taken for an unspecified indication, start and stop date were not reported and OTC seasonal allergy medications. The patient had known allergies for Levaquin. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 17Feb2021 09:30 AM (Batch/Lot Number: EL9266) as dose 1, single for covid-19 immunization. On 11Mar2021 07:00 AM, after 18 hours of post vaccination, the patient experienced chills, low grade fever and headache. The patient not received treatment. The outcome of the events was recovered on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752319
Sex: M
Age:
State: NV

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Shoulder and forearm ache and pain; Shoulder and forearm ache and pain; This is a spontaneous report received from a contactable consumer or other non hcp.A 86-years-old male patient received bnt162b2 (COMIRNATY,Batch/Lot Number: EN6200), via an unspecified route of administration, administered in Arm Left on 23Feb2021 14:00,at the age of 86 years old,as Dose number unknown,single for covid-19 immunization.Medical history included none from an unknown date and unknown if ongoing.There were no concomitant medications. The patient experienced shoulder and forearm ache and pain, shoulder and forearm ache and pain on 24Feb2021 03:00.The patient had not received any other vaccine in 4 weeks.The patient had not received any other medications within 2 weeks.The patient was not diagnosed with covid prior vaccination and not tested post vaccination.The patient didn't receive any treatment for the event.The patient reported no allergy.The outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752320
Sex: F
Age:
State: MI

Vax Date: 03/04/2021
Onset Date: 03/05/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 202103; Test Name: Blood work; Result Unstructured Data: Test Result:Good; Test Date: 202103; Test Name: chest x-ray; Result Unstructured Data: Test Result:Good; Test Date: 202103; Test Name: oxygen level; Result Unstructured Data: Test Result:Good

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Within a day I began to feel pressure in my chest and was feeling like I could not get enough air; Also, at times it was/is difficult to talk; Slight headache; lightheadedness; This is a spontaneous report from a contactable consumer or other non hcp female consumer (patient). A 67-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No: EN6202), via an unspecified route of administration, administered in Arm Right on 04Mar2021 10:15 as 1st dose, single for covid-19 immunisation (Age at vaccination was 67 years). Patient was pregnant at time of vaccination. Medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, varicose vein from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) taken for an unspecified indication, start and stop date were not reported; liothyronine sodium (CYTOMEL) taken for an unspecified indication, start and stop date were not reported; loratadine (CLARITIN [LORATADINE]) taken for an unspecified indication, start and stop date were not reported; estradiol, estriol, estrone (TRIEST) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The patient previously took lamisil [terbinafine hydrochloride] and experienced drug hypersensitivity, tetanus vaccine and experienced drug hypersensitivity, betadine [povidone-iodine] and experienced drug hypersensitivity, gantrisine and experienced drug hypersensitivity. The patient experienced within a day i began to feel pressure in my chest and was feeling like i could not get enough air, also, at times it was/is difficult to talk, slight headache, light headedness on 05Mar2021. The patient underwent lab tests and procedures which included blood test: good on Mar2021, chest x-ray: good on Mar2021, oxygen saturation: good on Mar2021.If other vaccine in four weeks was no.AE resulted in emergency room/department or urgent care. No, treatment was received. If covid prior vaccination was no. If covid tested post vaccination was unknown. Outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1752321
Sex: F
Age:
State: FL

Vax Date: 03/10/2021
Onset Date: 03/11/2021
Rec V Date: 10/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Severe body aches; chills; fatigue; headache; light headedness; sore throat; joint pain; This is a spontaneous report from a contactable other HCP (patient) reporting for herself. A 32-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ENU199), via an unspecified route of administration, administered in Left arm on 10Mar2021 09:45 at the age of 32-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included sertraline (SERTRALINE) taken for an unspecified indication, start and stop date were not reported; clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL9267), via an unspecified route of administration, administered in Left arm on 17Feb2021 at the age of 32-years-old as single dose for covid-19 immunisation. The patient previously took acetaminophen and experienced allergy. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 11Mar2021 at 01:00, the patient experienced Severe body aches, chills, fatigue, headache, light headedness, sore throat and joint pain. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for adverse events. The outcome of events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: Pfizer, Inc. 027034; Pfizer, Inc. 027034

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am